Ask Our Doctors and Nurses!

ERYTHROMYCIN Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

ERYTHROMYCIN Safety Reports

Total ERYTHROMYCIN reports: 55.
ERYTHROMYCIN FDA safety alerts: No.
Reported deaths: 4    Reported hospitalizations: 33.
Take ERYTHROMYCIN Side Effects Survey or Share Your ERYTHROMYCIN Story. Read More Here.

Consumer or non-health professional from UNITED STATES reported ERYTHROMYCIN problem on Jan 02, 2007. Female patient, weighting 125.1 lb, was diagnosed with acne and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: deafness, diarrhoea, dysstasia, paraesthesia, paralysis, vomiting, white blood cell count increased. ERYTHROMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 17, 2007. Male patient, 67 years of age, weighting 159.2 lb, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. ERYTHROMYCIN dosage: 250MG X 1 IV. Patient recovered.

Physician from UNITED KINGDOM reported ERYTHROMYCIN problem on Feb 01, 2007. Female patient, 63 years of age, weighting 132.3 lb, was diagnosed with skin laceration, pain, osteoporosis prophylaxis and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: depression suicidal, gastrointestinal disorder, nausea. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN W, OSTEOCE. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 15, 2007. Male patient was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: caesarean section, congenital anomaly, foetal arrhythmia, oligohydramnios, stillbirth. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PREDNISOLONE, MINOCYCLINE, OXYTETRACYCLINE. Patient died.

Health Professional from UNITED KINGDOM reported ERYTHROMYCIN problem on Feb 12, 2007. Female patient, 79 years of age, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: amnesia, anaemia, cellulitis, confusional state, diarrhoea, faecal incontinence, feeling abnormal, malaise, urinary tract infection. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, ATORVASTATIN, NIFEDIPINE, DOXAZOSIN MESYLATE, IRBESARTAN, ISPAGHULA, RAMIPRIL. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 13, 2007. Female patient, 79 years of age, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: amnesia, cellulitis, confusional state, diarrhoea, faecal incontinence, malaise, urinary tract infection. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with TEGRETOL, ATORVASTATIN, CARDURA, DOXAZOSIN MESYLATE, IRBESARTAN, NIFEDIPINE, PLANTAGO OVATA, RAMIPRIL. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported ERYTHROMYCIN problem on Feb 13, 2007. Female patient, 79 years of age, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: amnesia, cellulitis, confusional state, diarrhoea, faecal incontinence, malaise, urinary tract infection. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with TEGRETOL, ZINC ACETAT, ATORVASTATIN CALCIUM, CADURA, DOXAZOSIN, IRBESARTAN, NIFEDIPINE, PLANTAGO OVATA. Patient recovered.

ERYTHROMYCIN problem was reported by a Physician from UNITED KINGDOM on Feb 20, 2007. Female patient, 69 years of age, weighting 275.6 lb, was diagnosed with lower respiratory tract infection and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, pancytopenia. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with CHOLESTYRAMINE, ARTHROTEC. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported ERYTHROMYCIN problem on Mar 12, 2007. Female patient, 69 years of age, weighting 275.6 lb, was diagnosed with lower respiratory tract infection and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal, pancytopenia. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with CHOLESTYRAMINE, ARTHROTEC. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Health Professional from UNITED STATES on Apr 19, 2007. Female patient, 52 years of age, weighting 131.0 lb, was diagnosed with impaired gastric emptying and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chest pain, syncope, ventricular tachycardia. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with LISINOPRIL, ZELNORM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported ERYTHROMYCIN problem on May 09, 2007. Male patient, 44 years of age, weighting 138.9 lb, was diagnosed with pneumonia, pyrexia, cough and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with ERYTHROMYCIN BASE, PRULIFLOXACIN, CEFPIROME SULPHATE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, IMIPENEN, PAZUFLOXACIN MESILATE. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Health Professional from UNITED STATES on May 10, 2007. Female patient, 52 years of age, weighting 131.0 lb, was diagnosed with impaired gastric emptying and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chest pain, syncope, ventricular tachycardia. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with LISINOPRIL, ZELNORM. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported ERYTHROMYCIN problem on May 25, 2007. Female patient, 68 years of age, weighting 249.1 lb, was diagnosed with impaired gastric emptying and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: electrocardiogram qt corrected interval prolonged, torsade de pointes. ERYTHROMYCIN dosage: 500 MG IV Q6H. During the same period patient was treated with METOCLOPRAMIDE, MEGACE, DIFLUCAN. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Health Professional from UNITED STATES on May 24, 2007. Female patient, 52 years of age, weighting 131.0 lb, was diagnosed with impaired gastric emptying and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chest pain, syncope, ventricular tachycardia. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with LISINOPRIL, ZELNORM, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Physician from UNITED KINGDOM reported ERYTHROMYCIN problem on June 01, 2007. Male patient, 17 years of age, was diagnosed with acne and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, neutrophilia, red blood cell sedimentation rate increased. ERYTHROMYCIN dosage: unknown. Patient recovered.

ERYTHROMYCIN problem was reported by a Physician from UNITED KINGDOM on June 02, 2006. Male patient, weighting 153.9 lb, was diagnosed with rosacea, benign prostatic hyperplasia, labyrinthitis, chronic obstructive pulmonary disease and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: choking, cough, lower respiratory tract infection, lung disorder. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with FINASTERIDE, BETAHISTINE, SALBUTAMOL W. Patient was hospitalized. Patient recovered.

Physician from CANADA reported ERYTHROMYCIN problem on July 13, 2006. Female patient, 15 years of age, was diagnosed with overdose and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: overdose, pancreatitis acute. ERYTHROMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Pharmacist from UNITED STATES on July 20, 2006. Male patient, 64 years of age, weighting 224.0 lb, was diagnosed with infection, scarlet fever and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: heart rate irregular. ERYTHROMYCIN dosage: 250 MG Q6H. During the same period patient was treated with POTASSIUM CHLORIDE, SIMVASTATIN, GLIPIZIDE, METFORMIN HYDROCHLORIDE, TERAZOSIN, PAROXETINE. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported ERYTHROMYCIN problem on July 18, 2006. Male patient, 26 years of age, weighting 185.2 lb, was diagnosed with acne and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis, syncope. ERYTHROMYCIN dosage: unknown. Patient recovered.

ERYTHROMYCIN problem was reported by a Health Professional from UNITED KINGDOM on July 27, 2006. Male patient, 69 years of age, was diagnosed with rash and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: arthralgia, haemorrhage. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with WARFARIN, BENDROFLUMETHIAZIDE, DIGOXIN, FELODIPINE, RAMIPRIL. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported ERYTHROMYCIN problem on July 26, 2006. Female patient, 65 years of age, was diagnosed with lower respiratory tract infection, epilepsy, prophylaxis against gastrointestinal ulcer, schizophrenia and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: confusional state, hypotension, malaise, somnolence, vomiting. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, LEVOTHYROXINE, LANSOPRAZOLE, ASPIRIN, CLOPIXOL, DICLOFENAC, FOLIC ACID, INDAPAMIDE. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 27, 2006. Female patient, 36 years of age, was diagnosed with premature rupture of membranes and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: caesarean section, clostridium difficile colitis, hypotension, influenza like illness, premature rupture of membranes, pseudomembranous colitis, umbilical cord prolapse. ERYTHROMYCIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported ERYTHROMYCIN problem on Aug 21, 2006. Female patient, weighting 330.7 lb, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: adrenal insufficiency, circulatory collapse, confusional state, malaise, rhabdomyolysis, sepsis, skin ulcer. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with SIMVASTATIN, AMITRIPTYLINE, BUMETANIDE, DIHYDROCODEINE, LISINOPRIL, METFORMIN, ROSIGLITAZONE, THYROXINE. Patient was hospitalized and became disabled. Patient died on 04/02/2006.

ERYTHROMYCIN problem was reported by a Health Professional from UNITED KINGDOM on May 02, 2006. Female patient, weighting 330.7 lb, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, decubitus ulcer, infected skin ulcer, malaise, renal failure acute, rhabdomyolysis, skin necrosis, syncope. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with SIMVASTATIN, DIHYDROCODEINE, AMITRIPTYLINE, BUMETANIDE, LEVOTHYROXINE, LISINOPRIL, METFORMIN, ROSIGLITAZONE. Patient was hospitalized. Patient died on 04/02/2006.

Physician from JAPAN reported ERYTHROMYCIN problem on Aug 22, 2006. Male patient, child 8 years of age, weighting 46.30 lb, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic function abnormal, pyrexia, vomiting. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PEMIROLAST POTASSIUM. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 21, 2006. Female patient, weighting 330.7 lb, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: confusional state, decubitus ulcer, fall, infected skin ulcer, renal failure acute, rhabdomyolysis, sepsis. ERYTHROMYCIN dosage: 500 MG TID ORAL. During the same period patient was treated with SIMVASTATIN, AMITRYPTYLINE, BUMETANIDE, DIHYDROCODODEINE, LISINOPRIL, METFORMIN, ROSIGLITAZONE, THYROXINE. Patient was hospitalized and became disabled. Patient died on 04/02/2006.

Health Professional from UNITED KINGDOM reported ERYTHROMYCIN problem on Jan 23, 2006. Male patient, 73 years of age, was diagnosed with dermatitis, blood pressure increased and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: hypertension. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with AMLODIPINE, BETHAMEASONE, HYDROCORTISONE. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Sept 20, 2006. Male patient, 40 years of age, weighting 119.0 lb, was diagnosed with bacterial infection, influenza and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: haemodialysis, renal impairment. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PRIMAXIN, AMANTADINE, IMMUNE GLOBULIN INTRAVENOUS, CATECHOLAMINE, ULINASTATIN, SULTAMICILLIN TOSILATE, SULPERAZON, CLINDAMYCIN. Patient recovered.

Physician from JAPAN reported ERYTHROMYCIN problem on Aug 22, 2006. Male patient, weighting 46.30 lb, was diagnosed with chronic sinusitis, hypersensitivity and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic function abnormal, pyrexia, vomiting. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PEMIROLAST POTASSIUM, PEMIROLAST POTASSIUM. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Sept 20, 2006. Male patient, 40 years of age, weighting 119.0 lb, was diagnosed with bacterial infection, influenza and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: renal impairment. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PRIMAXIN, AMANTADINE, IMMUNE GLOBULIN INTRAVENOUS, CATECHOLAMINE, ULINASTATIN, SULTAMICILLIN TOSILATE, SULPERAZON, CLINDAMYCIN. Patient recovered.

Health Professional from NORWAY reported ERYTHROMYCIN problem on Oct 16, 2006. Female patient, 55 years of age, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic enzyme increased. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with DESLORATADINE. Patient recovered.

ERYTHROMYCIN problem was reported by a Physician from JAPAN on Aug 22, 2006. Male patient, weighting 46.30 lb, was diagnosed with chronic sinusitis, hypersensitivity and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic function abnormal, pyrexia, vomiting. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PEMIROLAST POTASSIUM, PEMIROLAST POTASSIUM. Patient was hospitalized. Patient recovered.

Physician from NORWAY reported ERYTHROMYCIN problem on Oct 16, 2006. Female patient, 55 years of age, was diagnosed with urticaria and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: cholestasis, hepatic enzyme increased. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with DESLORATADINE, NSAID, LOSARTAN POTASSIUM. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 27, 2006. Male patient, 80 years of age, weighting 121.3 lb, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with SIMVASTATIN, BUMETANIDE, CARDICOR, DIGOXIN, LANSOPRAZOLE, TRAMADOL, WARFARIN. Patient was hospitalized and became disabled. Patient recovered.

Physician from UNITED KINGDOM reported ERYTHROMYCIN problem on June 02, 2006. Male patient, weighting 153.9 lb, was diagnosed with rosacea, benign prostatic hyperplasia, labyrinthitis, chronic obstructive pulmonary disease and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: choking, cough, lower respiratory tract infection, lung disorder. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with FINASTERIDE, BETAHISTINE, SALBUTAMOL W. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 27, 2006. Male patient, 80 years of age, weighting 121.3 lb, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with SIMVASTATIN, BUMETANIDE, CARDICOR, DIGOXIN, LANSOPRAZOLE, TRAMADOL, WARFARIN. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from UNITED KINGDOM reported ERYTHROMYCIN problem on Nov 01, 2006. Female patient, 55 years of age, was diagnosed with reflux oesophagitis, blood cholesterol increased and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: nausea, vertigo, vomiting. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with CLINDAMYCIN, OMEPRAZOLE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Sept 20, 2006. Male patient, weighting 119.0 lb, was diagnosed with pneumonia, bacterial infection, influenza, shock and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: renal failure. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PRIMAXIN, AMANTADINE, IMMUNE GLOBULIN INTRAVENOUS, CATECHOLAMINE, ULINASTATIN, SULTAMICILLIN TOSILATE, SULPERAZON, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported ERYTHROMYCIN problem on Sept 20, 2006. Male patient, weighting 119.0 lb, was diagnosed with pneumonia, bacterial infection, influenza, shock and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: renal failure. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PRIMAXIN, AMANTADINE, IMMUNE GLOBULIN INTRAVENOUS, CATECHOLAMINE, ULINASTATIN, SULTAMICILLIN TOSILATE, SULPERAZON, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Sept 20, 2006. Male patient, weighting 119.0 lb, was diagnosed with pneumonia, bacterial infection, influenza, shock and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: renal failure. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PRIMAXIN, AMANTADINE, IMMUNE GLOBULIN INTRAVENOUS, CATECHOLAMINE, ULINASTATIN, SULTAMICILLIN TOSILATE, SULPERAZON, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported ERYTHROMYCIN problem on Sept 20, 2006. Male patient, weighting 119.0 lb, was diagnosed with pneumonia, bacterial infection, influenza, shock and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: renal failure. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PRIMAXIN, AMANTADINE, IMMUNE GLOBULIN INTRAVENOUS, CATECHOLAMINE, ULINASTATIN, SULTAMICILLIN TOSILATE, SULPERAZON, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Nov 08, 2006. Male patient, 44 years of age, was diagnosed with pneumonia, pyrexia, cough and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: eosinophilic pneumonia. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PRULIFLOXACIN, CEFPIROME SULPHATE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, PRIMAXIN, PAZUFLOXACIN MESILATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported ERYTHROMYCIN problem on Sept 20, 2006. Male patient, weighting 119.0 lb, was diagnosed with pneumonia, bacterial infection, influenza, shock and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: haemodialysis, renal failure. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PRIMAXIN, AMANTADINE, IMMUNE GLOBULIN INTRAVENOUS, CATECHOLAMINE, ULINASTATIN, SULTAMICILLIN TOSILATE, SULPERAZON, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from JAPAN on Nov 08, 2006. Male patient, 44 years of age, weighting 138.9 lb, was diagnosed with pneumonia, pyrexia, cough and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: antibody test positive, blood alkaline phosphatase increased, bronchoalveolar lavage abnormal, candidiasis, chlamydial infection, eosinophilic pneumonia, escherichia infection, fungus culture positive. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PRULIFLOXACIN, CEFPIROME SULPHATE, MINOCYCLINE, IMIPENEN, PAZUFLOXACIN MESILATE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported ERYTHROMYCIN problem on Feb 24, 2005. Female patient, 28 years of age, was diagnosed with rosacea and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: gestational diabetes, oligohydramnios. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PREDNISOLONE, INSULIN. Patient died.

ERYTHROMYCIN problem was reported by a Health Professional from UNITED KINGDOM on Dec 11, 2006. Female patient, 27 years of age, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: amniotic fluid volume decreased. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with BETAMETHASONE, CEFUROXIME, METRONIDAZOLE. Patient was hospitalized. Patient died.

Consumer or non-health professional from UNITED KINGDOM reported ERYTHROMYCIN problem on Dec 07, 2006. Female patient, 27 years of age, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, amniotic fluid volume decreased. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with BETAMETHASONE, CEFUROXIME, METRONIDAZOLE. Patient died.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 07, 2006. Female patient, 27 years of age, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, amniotic fluid volume decreased, premature rupture of membranes. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with BETAMETHASONE, CEFUROXIME, METRONIDAZOLE. Patient died.

Consumer or non-health professional from UNITED KINGDOM reported ERYTHROMYCIN problem on Dec 07, 2006. Female patient, 27 years of age, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, amniotic fluid volume decreased, twin pregnancy. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with BETAMETHASONE, CEFUROXIME, METRONIDAZOLE. Patient died.

ERYTHROMYCIN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 20, 2007. Female patient, 28 years of age, was diagnosed with rosacea and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: body mass index increased, caesarean section, gestational diabetes, oligohydramnios. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with PREDNISOLONE, DINOPROSTONE, MIFEPRISTONE, MISOPROSTOL. Patient died.

Health Professional from UNITED STATES reported ERYTHROMYCIN problem on Aug 03, 2007. Male patient, weighting 10.74 lb, was diagnosed with chlamydial infection, conjunctivitis and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chlamydial infection, pyloric stenosis, sepsis, vomiting. ERYTHROMYCIN dosage: 50 MG Q6HR PO. During the same period patient was treated with CEFOTAXIME. Patient was hospitalized. Patient recovered.

ERYTHROMYCIN problem was reported by a Pharmacist from UNITED KINGDOM on Aug 06, 2007. Male patient, 14 years of age, was diagnosed with tooth infection and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chest pain. ERYTHROMYCIN dosage: unknown. Patient recovered.

Pharmacist from UNITED KINGDOM reported ERYTHROMYCIN problem on Aug 23, 2007. Male patient, weighting 103.6 lb, was diagnosed with tooth abscess, type 1 diabetes mellitus, asthma and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chest pain. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with NOVOMIX, INSULIN ASPART, INSULIN GLARGINE, BECLOMETHASONE DIPROPIONATE. Patient recovered.

ERYTHROMYCIN problem was reported by a Pharmacist from UNITED KINGDOM on Aug 23, 2007. Male patient, weighting 103.6 lb, was diagnosed with tooth abscess, type 1 diabetes mellitus, asthma and was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: chest pain. ERYTHROMYCIN dosage: unknown. During the same period patient was treated with NOVOMIX, INSULIN ASPART, INSULIN GLARGINE, BECLOMETHASONE DIPROPIONATE. Patient recovered.

Physician from UNITED KINGDOM reported ERYTHROMYCIN problem on Sept 03, 2007. Female patient, 37 years of age, was treated with ERYTHROMYCIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. ERYTHROMYCIN dosage: unknown. Patient recovered.